NorthWest Biotherapeutics Inc (NWBO)

[alphapuppy]

Worst case scenario in this analysis the median overall survival for the blended group, was 17.7 months. With an upper and lower 95% confidence interval’s listed in the post.

This is worst case because this analysis utilize that IMUC Control group survival curves to form the basis but utilized the number of the events previously disclosed by management / principal investigators, in the DC trial.

The hypothesis is however that these patients most of Whom received the vaccine, either initially or at relapse, will actually survive better than the control group of the IMUC Patient cohort.